Sleep Disorders

>

Latest News

ADA 84th Scientific Sessions: 3 Studies Primary Care Clinicians Should Put on Their Radar / Image credit: ©lyrna/AdobeStock
ADA 84th Scientific Sessions: 3 Studies Primary Care Clinicians Should Put on Their Radar

June 20th 2024

Details on tirzepatide for obesity-related obstructive sleep apnea, semaglutide for prevention of major kidney outcomes in patients with T2D and CKD, more.

ADA 84th Scientific Sessions Preview: STEP-HFp-EF Trial Data, Tirzepatide for Obesity-Related OSA, Optimizing Diabetes Care in Primary Care / Image credit: ©Minerva Studio/Shutterstock.com
ADA 84th Scientific Sessions Preview: STEP-HFp-EF Trial Data, Tirzepatide for Obesity-Related OSA, Optimizing Diabetes Care in Primary Care

June 17th 2024

Tirzepatide Significantly Reduces OSA Symptoms in Phase 3 Trials, Lilly Looks Toward Regulatory Submission  / image credit obese man asleep / ©motortion/stock.adobe.com
Tirzepatide Significantly Reduces OSA Symptoms in Phase 3 Trials, Lilly Looks Toward Mid-2024 Regulatory Submission

April 17th 2024

Women with Poor Sleep During Midlife at Significantly Elevated Risk for Future CVD / image credit woman with insomnia ©motortion/stock.adobe.com
Women with Poor Sleep During Midlife at Significantly Elevated Risk for Future CVD

February 13th 2024

Vagus Nerve Stimulation in Narcolepsy: Daily Dose / image credit: ©New Africa/AdobeStock
Vagus Nerve Stimulation in Narcolepsy: Daily Dose

February 6th 2024

Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.